Wilbur James 4
4 · 10x Genomics, Inc. · Filed Mar 23, 2023
Insider Transaction Report
Form 4
Wilbur James
Chief Commercial Officer
Transactions
- Award
Class A Common Stock
2023-03-21+14,555→ 110,394 total - Award
Stock Option (right to buy)
2023-03-21+14,555→ 14,555 totalExercise: $50.10Exp: 2033-03-21→ Class A Common Stock (14,555 underlying) - Award
Performance-based Restricted Stock Units
2023-03-21+7,278→ 7,278 totalExp: 2028-04-01→ Class A Common Stock (7,278 underlying)
Footnotes (3)
- [F1]Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a service provider through each such date.
- [F3]Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date.